Stage IIIB Breast Cancer Terminated Phase 3 Trials for Trastuzumab (DB00072)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00016276Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast CancerTreatment